Title:
作用の発現を促進するアセチルサルチル酸を含んで成る経口抗うつ製剤
Document Type and Number:
Japanese Patent JP2007509838
Kind Code:
A
Abstract:
Oral antidepressant formulation comprising an effective antidepressant amount of one or more pharmaceutically acceptable antidepressant active agents advantageously selected of he group consisting of SSRIs, SNRIs (serotonin nordraline reuptake inhibitors) CRF antagonists, NK1 antagonists, NK2 antagonists, NK3 antagonists and combinations thereof, and an effective amount lower than 50mg of at least a compound selected from the group consisting of acetylsalicylic acid, derivatives of acetylsalicylic acid, and mixtures thereof, for reducing the onset of antidepressant action.
Inventors:
Mendre Wicks, Julien
Criwin, Philip
Powys De Tembocher, Roland
Criwin, Philip
Powys De Tembocher, Roland
Application Number:
JP2005509765A
Publication Date:
April 19, 2007
Filing Date:
October 29, 2003
Export Citation:
Assignee:
Mendre Wicks, Julien
Criwin, Philip
Powys De Tembocher, Roland
Criwin, Philip
Powys De Tembocher, Roland
International Classes:
A61K31/616; A61K31/00; A61K31/138; A61K45/00; A61K45/06; A61P25/24; A61P43/00
Other References:
JPN6010023133, 安藤 英祐, 医学のあゆみ, 2002, Ｖｏｌ．２００， Ｎｏ．１３, ｐ１０６３
JPN7010001301, ＮＥＷ薬理学, 2002, ｐ２９０−２９６
JPN6010023134, ＫＲＵＭＨＯＬＺ，Ｗ．Ｖ． ｅｔ ａｌ, "Ｓｔｕｄｉｅｓ ｗｉｔｈ ａｃｅｔｙｌｓａｌｉｃｙｌｉｃ ａｃｉｄ． ＩＩ． Ｐｓｙｃｈｏｐｈａｒｍａｃｏｌｏｇｉｃ ａｎｄ ｍｅｔｈｏｄｏｌｏｇｉｃ ｃｏｎｓｉｄｅｒａｔｉｏｎｓ", ＣＬＩＮ ＰＨＡＲＭＡＣＯＬ ＴＨＥＲＡＰ, 1965, Ｖｏｌ．５， Ｎｏ．３, ｐ．３５９−３６１
JPN7010001301, ＮＥＷ薬理学, 2002, ｐ２９０−２９６
JPN6010023134, ＫＲＵＭＨＯＬＺ，Ｗ．Ｖ． ｅｔ ａｌ, "Ｓｔｕｄｉｅｓ ｗｉｔｈ ａｃｅｔｙｌｓａｌｉｃｙｌｉｃ ａｃｉｄ． ＩＩ． Ｐｓｙｃｈｏｐｈａｒｍａｃｏｌｏｇｉｃ ａｎｄ ｍｅｔｈｏｄｏｌｏｇｉｃ ｃｏｎｓｉｄｅｒａｔｉｏｎｓ", ＣＬＩＮ ＰＨＡＲＭＡＣＯＬ ＴＨＥＲＡＰ, 1965, Ｖｏｌ．５， Ｎｏ．３, ｐ．３５９−３６１
Attorney, Agent or Firm:
Ippei Watanabe
Koji Kikawa
Koji Kikawa